SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

Roche Wins FDA Approval for Gazyva in Primary Membranous Nephropathy

The FDA approved Gazyva/Gazyvaro (obinutuzumab) for adults with primary membranous nephropathy, Roche says.

RHHBY

Related stories